News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Quark Pharmaceuticals Inc. Seeks Up to $20M IPO



9/27/2010 8:18:19 AM

San Francisco Business Times -- Quark Pharmaceuticals Inc., a developer of RNA interference drugs that signed a big deal last month with Novartis AG, wants to raise up to $20 million in the Bay Area’s latest biotech IPO.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES